The “Cancer Biology and Therapeutics” Section of Biomedicines (ISSN: 2227-9059) publishes reviews and original peer-reviewed papers of a high scientific standard, covering all the aspects of innovative cancer therapies. Papers aim to uncover novel therapeutic approaches toward overcoming conventional anticancer drug resistance, a better understanding of the interrelations between cancer and metabolism as well as tumors and microenvironments, along with the discovery of novel diagnostic and prognostic makers. Topics include but are not limited to in vitro and in vivo cancer therapeutic responses, targeted therapies (including metabolism and immunotherapy, such involving CAR-T cells), identification of novel therapeutic targets, and evaluation of novel diagnosis and prognosis markers and the assessment of their impact on morphological, phenotypical, and molecular classifications.

“Modulation of Intracellular Copper Levels as the Mechanism of Action of Anticancer Copper Complexes: Clinical Relevance”
by Maria V. Babak and Dohyun Ahn
Biomedicines 2021, 9(8), 852; https://doi.org/10.3390/biomedicines9080852
Available online: https://www.mdpi.com/2227-9059/9/8/852

“Advances and Limitations of Antibody Drug Conjugates for Cancer”
by Candice Maria Mckertish and Veysel Kayser
Biomedicines 2021, 9(8), 872; https://doi.org/10.3390/biomedicines9080872
Available online: https://www.mdpi.com/2227-9059/9/8/872

“Trifarotene: A Current Review and Perspectives in Dermatology”
by Terenzio Cosio, Monia Di Prete, Roberta Gaziano, Caterina Lanna, Augusto Orlandi, Paolo Di Francesco, Luca Bianchi and Elena Campione
Biomedicines 2021, 9(3), 237; https://doi.org/10.3390/biomedicines9030237
Available online: https://www.mdpi.com/2227-9059/9/3/237

“Targeting Glioblastoma Stem Cells to Overcome Chemoresistance: An Overview of Current Therapeutic Strategies”
by Hyunkoo Kang, Haksoo Lee, Dahye Kim, Byeongsoo Kim, JiHoon Kang, Hae Yu Kim, HyeSook Youn and BuHyun Youn
Biomedicines 2022, 10(6), 1308; https://doi.org/10.3390/biomedicines10061308
Available online: https://www.mdpi.com/2227-9059/10/6/1308

“The Hallmarks of Glioblastoma: Heterogeneity, Intercellular Crosstalk and Molecular Signature of Invasiveness and Progression”
by Filippo Torrisi, Cristiana Alberghina, Simona D’Aprile, Anna M. Pavone, Lucia Longhitano, Sebastiano Giallongo, Daniele Tibullo, Michelino Di Rosa, Agata Zappalà, Francesco P. Cammarata et al.
Biomedicines 2022, 10(4), 806; https://doi.org/10.3390/biomedicines10040806
Available online: https://www.mdpi.com/2227-9059/10/4/806

“MiR-7 in Cancer Development”
by Petra Korać, Mariastefania Antica and Maja Matulić
Biomedicines 2021, 9(3), 325; https://doi.org/10.3390/biomedicines9030325
Available online: https://www.mdpi.com/2227-9059/9/3/325

“Targeting STAT3 Signaling Pathway in Colorectal Cancer”
by Antonios N. Gargalionis, Kostas A. Papavassiliou and Athanasios G. Papavassiliou
Biomedicines 2021, 9(8), 1016; https://doi.org/10.3390/biomedicines9081016
Available online: https://www.mdpi.com/2227-9059/9/8/1016

“Circulating Tumor Cells: Technologies and Their Clinical Potential in Cancer Metastasis”
by Jerry Xiao, Paula R. Pohlmann, Claudine Isaacs, Benjamin A. Weinberg, Aiwu R. He, Richard Schlegel and Seema Agarwal
Biomedicines 2021, 9(9), 1111; https://doi.org/10.3390/biomedicines9091111
Available online: https://www.mdpi.com/2227-9059/9/9/1111

“CK2 Regulation: Perspectives in 2021”
by Scott E. Roffey and David W. Litchfield
Biomedicines 2021, 9(10), 1361; https://doi.org/10.3390/biomedicines9101361
Available online: https://www.mdpi.com/2227-9059/9/10/1361

“Glycobiology of the Epithelial to Mesenchymal Transition”
by Michela Pucci, Nadia Malagolini and Fabio Dall’Olio
Biomedicines 2021, 9(7), 770; https://doi.org/10.3390/biomedicines9070770
Available online: https://www.mdpi.com/2227-9059/9/7/770

We would appreciate it if you would circulate the link of any of the papers you find appealing into your network.

Submitting a manuscript:
This Section is currently open for submissions. Papers may be submitted via the following link: https://susy.mdpi.com/user/manuscripts/upload/f17a01dbff7541081d1092edf09cd870?form%5Bjournal_id%5D=158.

Launching a Special Issue:
You have the opportunity to propose hot topics and edit a Special Issue together with experts in the field. Special Issue proposals can be submitted at the following link: https://www.mdpi.com/journalproposal/sendproposalspecialissue/biomedicines.

Joining the Editorial Board:
We are looking for active scholars who are interested in helping with the selection of submissions and please do not hesitate to get in touch in case you are interested in joining the Editorial Board ([email protected]).

Biomedicines Editorial Office